mbdnf (Santa Cruz Biotechnology)
Structured Review
Mbdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 257 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pro+bdnf/pro+BDNF+Antibody/pm41671728-128-26-52
Average 94 stars, based on 257 article reviews
Images
Related Articles
Incubation:Article Title: The astrocytic sigma-1 receptor constitutes in the fast antidepressant action of hypidone hydrochloride (YL-0919) in rodents Article Snippet: .. The membranes were blocked with 5% skim milk for 1 h at room temperature, and incubated with the following primary antibodies against sigma-1R (1:1,000, Cell signaling technology, 61994S), Article Title: Memory impairment in the D2. mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688 Article Snippet: .. Membranes were incubated with the appropriate primary antibodies as follows: APP (BioLegend 825001), soluble APPα (IBL 11088), soluble APPβ (BioLegend 813401), BACE1 (CST 5606), ADAM10 (Abcam ab1997), p‐tau (serine 202; CST 11834), total tau (CST 4019), p‐Raptor (serine 792; CST 2083), total Raptor (CST 2280), p‐p70s6K (thr389; CST 9206S), total p70s6k (Santa Cruz SC‐230), NeuN (CST 24307) and Article Title: Hyperbaric oxygen therapy enhances hippocampal long-term potentiation via upregulation of BDNF and p-CREB1 in rats: Evidence outside pathological models. Article Snippet: Hyperbaric oxygen therapy (HBOT) is known to confer neuroprotective benefits in injury models, but its in vivo effects on synaptic plasticity in the healthy brain remain unclear.. This study investigates HBOT’s impact on hippocampal long-term potentiation (LTP) and underlying molecular mechanisms in adult male Wistar rats.. Animals were randomized into Control (ambient air) and HBOT (100 % O2 at 2.4 ATA for 1 h daily) groups for seven days. Article Title: Memory impairment in the D2.<i>mdx</i> mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688 Article Snippet: All images were normalized to total protein from the samemembrane stained usingAmidoBlack total protein stain (A8181; Sigma). .. All remaining proteins were detected on 0.45 μmnitrocellulose and blockedwith 5%non-fat drymilk in TBS-T.Membraneswere incubated with the appropriate primary antibodies as follows: APP (BioLegend 825001), solubleAPPα (IBL11088), solubleAPPβ (BioLegend813401), BACE1 (CST 5606), ADAM10 (Abcam ab1997), p-tau (serine 202; CST 11834), total tau (CST 4019), p-Raptor (serine 792; CST 2083), total Raptor (CST 2280), p-p70s6K (thr389; CST 9206S), total p70s6k (Santa Cruz SC-230), NeuN (CST 24307) and Staining:Article Title: BDNF/Cyclin D1 Signaling System and Cognitive Performance After Perampanel and Lacosamide Treatment Singly or in Combination in an Experimental Model of Temporal Lobe Epilepsy Article Snippet: Lacosamide (Vimpat ® , USB Pharma, Brussels, Belgium), Perampanel (Fycompa ® , Eisai Ltd., Frankfurt am Main, Germany), and Diazepam (Sopharma, Sofia, Bulgaria) were obtained from the pharmaceutical companies. .. The following reagents were used in the study: Bouen’s Fluid Sigma, HT10132 (Aldrich Chemie GmbH, Taufkirchen, Germany); Gill’s Hematoxylin Solution, No. 2, sc-24973A (Santa Cruz Biotechnology, Inc., Dallas, TX, USA); ImmunoCruz goat ABC Staining, sc-2023 (Santa Cruz Biotechnology, Inc., Dallas, TX, USA); Article Title: BDNF/Cyclin D1 Signaling System and Cognitive Performance After Perampanel and Lacosamide Treatment Singly or in Combination in an Experimental Model of Temporal Lobe Epilepsy. Article Snippet: Lacosamide (Vimpat®, USB Pharma, Brussels, Belgium), Perampanel (Fycompa®, Eisai Ltd., Frankfurt am Main, Germany), and Diazepam (Sopharma, Sofia, Bulgaria) were obtained from the pharmaceutical companies. .. The following reagents were used in the study: Bouen’s Fluid Sigma, HT10132 (Aldrich Chemie GmbH, Taufkirchen, Germany); Gill’s Hematoxylin Solution, No. 2, sc-24973A (Santa Cruz Biotechnology, Inc., Dallas, TX, USA); ImmunoCruz goat ABC Staining, sc-2023 (Santa Cruz Biotechnology, Inc., Dallas, TX, USA); Binding Assay:Article Title: Hyperbaric oxygen therapy enhances hippocampal long-term potentiation via upregulation of BDNF and p-CREB1 in rats: Evidence outside pathological models. Article Snippet: Hyperbaric oxygen therapy (HBOT) is known to confer neuroprotective benefits in injury models, but its in vivo effects on synaptic plasticity in the healthy brain remain unclear.. This study investigates HBOT’s impact on hippocampal long-term potentiation (LTP) and underlying molecular mechanisms in adult male Wistar rats.. Animals were randomized into Control (ambient air) and HBOT (100 % O2 at 2.4 ATA for 1 h daily) groups for seven days. Blocking Assay:Article Title: Hyperbaric oxygen therapy enhances hippocampal long-term potentiation via upregulation of BDNF and p-CREB1 in rats: Evidence outside pathological models. Article Snippet: Hyperbaric oxygen therapy (HBOT) is known to confer neuroprotective benefits in injury models, but its in vivo effects on synaptic plasticity in the healthy brain remain unclear.. This study investigates HBOT’s impact on hippocampal long-term potentiation (LTP) and underlying molecular mechanisms in adult male Wistar rats.. Animals were randomized into Control (ambient air) and HBOT (100 % O2 at 2.4 ATA for 1 h daily) groups for seven days. Bioprocessing:Article Title: Hyperbaric oxygen therapy enhances hippocampal long-term potentiation via upregulation of BDNF and p-CREB1 in rats: Evidence outside pathological models. Article Snippet: Hyperbaric oxygen therapy (HBOT) is known to confer neuroprotective benefits in injury models, but its in vivo effects on synaptic plasticity in the healthy brain remain unclear.. This study investigates HBOT’s impact on hippocampal long-term potentiation (LTP) and underlying molecular mechanisms in adult male Wistar rats.. Animals were randomized into Control (ambient air) and HBOT (100 % O2 at 2.4 ATA for 1 h daily) groups for seven days. Methylation:Article Title: Synergistic suppression of BDNF via epigenetic mechanism deteriorating learning and memory impairment caused by Mn and Pb co-exposure. Article Snippet: Microglia, the resident immune cells of the central nervous system (CNS), play a dual role in neurotoxicity by releasing the NLR Family Pyrin Domain Containing 3 (NLRP3) inflammasome and brain-derived neurotrophic factor (BDNF) in response to environmental stress.. Suppression of BDNF is implicated in learning and memory impairment induced by exposure to manganese (Mn) or lead (Pb) individually.. Methyl CpG Binding Protein 2 (MeCp2) and its phosphorylation status are related to BDNF suppression. |
